CB
ABBV icon

Chris Bulman’s AbbVie ABBV Stock Holding History

Chris Bulman’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$504K Buy
2,003
+20
+1% +$4.3K 0.18% 86
2026
Q1 		$431K Buy
1,983
+113
+6% +$25.1K 0.19% 84
2025
Q4 		$427K Buy
1,870
+133
+8% +$30.3K 0.19% 78
2025
Q3 		$402K Sell
1,737
-516
-23% -$105K 0.2% 74
2025
Q2 		$418K Sell
2,253
-370
-14% -$68.8K 0.24% 72
2025
Q1 		$550K Buy
2,623
+140
+6% +$27.2K 0.35% 60
2024
Q4 		$441K Buy
2,483
+19
+0.8% +$3.49K 0.28% 65
2024
Q3 		$487K Buy
2,464
+15
+0.6% +$2.8K 0.33% 62
2024
Q2 		$420K Buy
+2,449
New +$406K 0.29% 63

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chris Bulman's ABBV Position: Q2 2026 in Review

Chris Bulman increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $4.3K and bringing the position to 2,003 shares worth $504K. The position accounts for 0.18% of the portfolio, ranked #86.

Chris Bulman first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $550K in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Chris Bulman held 2,003 shares of AbbVie worth $504K as of Q2 2026.
  • Chris Bulman bought 20 AbbVie shares in Q2 2026, an estimated $4.3K.
  • AbbVie made up 0.18% of Chris Bulman's portfolio in Q2 2026, its #86 holding.
  • Chris Bulman first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • Chris Bulman's AbbVie position peaked at $550K in Q1 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chris Bulman's 13F filing for Q2 2026, filed 22 Jul 2026.